FI
BIO icon

FormulaFolio Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

FormulaFolio Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$1K Hold
1
– – ﹤0.01% 455
2021
Q1 		$1K Buy
+1
New +$592 ﹤0.01% 425

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FormulaFolio Investments's BIO Position: Q2 2021 in Review

FormulaFolio Investments held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2021 at 1 share worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

FormulaFolio Investments first reported a position in BIO in Q1 2021 and has held it in 2 quarters since. 508 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • FormulaFolio Investments held 1 share of Bio-Rad Laboratories Class A worth $1K as of Q2 2021.
  • FormulaFolio Investments left its Bio-Rad Laboratories Class A share count unchanged in Q2 2021.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #455 holding.
  • FormulaFolio Investments first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and has held it in 2 quarters since.
  • 508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.